Gorgas Gregory D.
- SEC CIK
- 0001526251
No open-market purchases or sales filed in the past year.
Current role at each company
- ARTL Artelo Biosciences, Inc.Pres, CEO, CFO, Treas & Secras of Feb 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gorgas Gregory D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | May 1 | 4 days | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | PPurchaseConvertible Promissory Note | – | – | – | – | DerivativePrice outlier |
| Aug 12, 2022 (view filing) | Aug 12 | Same day | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | PPurchase | +1.20K | $4.00 | +$4.80K | +100.0%2.40K after | |
| Aug 11, 2022 (view filing) | Aug 11 | Same day | Gorgas Gregory D.Pres, CEO, CFO, Treas & Secr | PPurchase | +1.20K | $4.03 | +$4.84K | New position1.20K after |